HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Next-Generation Drugs for Diabetes Treatment

A surge of innovation in next-generation drugs for diabetes treatment is reshaping therapeutic strategies by targeting novel metabolic pathways. Beyond conventional insulin and oral hypoglycemics, recent developments include dual and triple agonists that simultaneously modulate multiple hormonal pathways, such as GLP-1/GIP receptor agonists. Sodium-glucose co-transporter inhibitors (SGLT1/SGLT2) continue to gain traction due to their cardiovascular and renal protective effects. Additionally, small-molecule insulin mimetics and gene-editing techniques are opening new avenues for disease-modifying treatments. Personalized medicine approaches and advancements in drug delivery systems, including smart insulin and implantable devices, are enhancing efficacy while minimizing side effects. These breakthroughs offer promising prospects for achieving sustained glycemic control and preventing diabetes-related complications.

Committee Members
Speaker at Diabetes and Endocrinology 2025 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical Center, United States
Speaker at Diabetes and Endocrinology 2025 - F Buck Willis

F Buck Willis

IUHS School of Medicine, Saint Kitts and Nevis
Speaker at Diabetes and Endocrinology 2025 - Gretchen Holmes

Gretchen Holmes

Memorial Hospital at Gulfport, United States
Diabetes 2025 Speakers
Speaker at Diabetes and Endocrinology 2025 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes and Endocrinology 2025 - Amy Gutman

Amy Gutman

AdventHealth; Tough Love MD, United States
Speaker at Diabetes and Endocrinology 2025 - Paraskevi Theofilou

Paraskevi Theofilou

Hellenic Open University, Greece
Speaker at Diabetes and Endocrinology 2025 - Clifford Morris

Clifford Morris

Kihealth, United States
Tags

Submit your abstract Today

Watsapp